PTGX Protagonist Therapeutics Inc

held by 1 manager in Q1 2026

Manager	% of their portfolio	Held	Activity	Value	Shares
Stanley Druckenmiller Duquesne Family Office	0.57%	9 mo	—	$17M	159,700

Search